long-acting injectable risperidone

DRUG3 trials

Sponsors

Seattle Institute for Biomedical and Clinical Research, Northwell Health, Northwestern University

Conditions

Methamphetamine DependencePsychotic Disorder Not Otherwise SpecifiedSchizoaffective DisorderSchizophreniaSchizophreniform Disorder

Phase 2

A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

CompletedNCT00284206

Seattle Institute for Biomedical and Clinical ResearchMethamphetamine Dependence

Start: 2006-01-31End: 2007-08-31Target: 20Updated: 2008-01-11

Phase 4

Optimizing Response in Psychosis Study

TerminatedNCT00314327

Northwell HealthPsychotic Disorder Not Otherwise Specified, Schizoaffective Disorder, Schizophrenia +1

Start: 2006-04-30End: 2013-11-30Updated: 2018-05-16

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

CompletedNCT00539071

Northwestern UniversitySchizoaffective Disorder, Schizophrenia

Start: 2008-03-31End: 2012-05-31Updated: 2025-10-01